“Recombinant in vitro production using antibody libraries and modern DNA technology, instead of laboratory animals and hybridoma cell lines, is particularly attractive for customers who are ...

More genes can then be introduced into a target cell to improve the efficiency of antibody production. Traditionally, hybridoma technology — a five-step process based on the fusion of antigen ...

Microfluidic technology enables high-throughput, droplet-based antibody discovery in fully human antibody mice.

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a ...

Cyto-Mine ® tackles the time-consuming and labor-intensive challenges of screening extensive cell populations for rare, antigen-specific antibody-secreting cells during antibody discovery.

(Image: National Cancer Institute) The production of monoclonal antibodies involves a multi-step process called hybridoma technology, which was first developed by Georges Köhler and César Milstein in ...

ImmunoPrecise Antibodies (IPA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company ...